Advertisement

Zinnat 125mg/5ml

Hauptinformation

  • Handelsname:
  • Zinnat 125mg/5ml - Granulat zur Herstellung einer Suspension zum Einnehmen
  • Einheiten im Paket:
  • 50 ml Suspension, Laufzeit: 24 Monate,100 ml Suspension, Laufzeit: 24 Monate,200 ml Suspension, Laufzeit: 24 Monate
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge
Advertisement

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Zinnat 125mg/5ml - Granulat zur Herstellung einer Suspension zum Einnehmen
    Österreich
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiebereich:
  • Cefuroxim

Weitere Informationen

Status

  • Quelle:
  • AGES
  • Zulassungsnummer:
  • 1-19967
  • Letzte Änderung:
  • 07-11-2016

24-11-2017

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries Inc. Issues Voluntary Nationwide Recall of Riomet® (Metformin Hydrochloride Oral Solution) Manufactured by a Contract Manufacturer due to Microbial Contamination

Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies) is voluntarily recalling two lots of Riomet® (Metformin Hydrochloride Oral Solution), 500 mg/5mL, to the retail level (Class II Recall). This product is manufactured for SPII by a contract manufacturer. The Riomet® (Metformin Hydrochloride Oral Solution) has been fo...

FDA - U.S. Food and Drug Administration

23-6-2017

Fagron Sterile Services Issues Voluntary Nationwide Recall of Succinylcholine Chloride Due to Potential For Lack of Sterility Assurance

Fagron Sterile Services Issues Voluntary Nationwide Recall of Succinylcholine Chloride Due to Potential For Lack of Sterility Assurance

Fagron Sterile Services is voluntarily recalling three (3) lots of Succinylcholine Chloride 20mg/mL 5mL syringe to the hospital/clinic level. The secondary recall of product manufactured by Hospira Inc., a Pfizer company, and repacked by Fagron Sterile Services is due to microbial growth detected during a routine simulation of Hospira’s manufacturing process, which represents the potential introduction of microorganisms into the product.

FDA - U.S. Food and Drug Administration

23-6-2017

Succinylcholine Chloride 20mg/mL 5mL Syringe by Fagron Sterile Services: Recall - Potential Lack Of Sterility Assurance

Succinylcholine Chloride 20mg/mL 5mL Syringe by Fagron Sterile Services: Recall - Potential Lack Of Sterility Assurance

Reasonable probability that patient may experience adverse events ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis.

FDA - U.S. Food and Drug Administration

1-2-2018

CEFUROXIME AXETIL Tablet [PD-Rx Pharmaceuticals, Inc.]

CEFUROXIME AXETIL Tablet [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Feb 1, 2018 EST

US - DailyMed

1-2-2018

01.02.2018: Carboplatin-Teva 50mg / 5ml, Infusionslösung, Durchstechflasche(n) à 5 ml, 19.50, -6.0%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer51481119 ZulassungsinhaberTeva Pharma AGNameCarboplatin-Teva 50mg / 5ml, InfusionslösungRegistrierungsdatum03.12.1992Original/GenerikumGenerikumErstzulassung Sequenz03.12.1992ATC-KlassierungCarboplatin (L01XA02)Revisionsdatum26.10.2007WHOWHO-DDDGültig bis25.10.2022Index Therapeuticus (BSV)07.16.10.PackungsgrösseDurchstechflasche(n) à 5 mlIndex Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungZytostatiku...

ODDB -Open Drug Database

1-2-2018

01.02.2018: Zoledronat Onco Labatec 4mg/5ml, concentré pour solution pour perfusion, Durchstechflasche(n), 192.70, -2.6%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer63012001 ZulassungsinhaberLabatec Pharma SANameZoledronat Onco Labatec 4mg/5ml, concentré pour solution pour perfusionRegistrierungsdatum16.04.2013Original/GenerikumGenerikumErstzulassung Sequenz16.04.2013ATC-KlassierungZoledronsäure (M05BA08)Revisionsdatum WHOWHO-DDDGültig bis15.04.2023Index Therapeuticus (BSV)07.99.PackungsgrösseDurchstechflasche(n)Index Therapeuticus (Swissmedic)07.99.Beschreibung AbgabekategorieB  SL EintragJaAnwen...

ODDB -Open Drug Database

1-2-2018

01.02.2018: Zoledronat-Teva onco 4mg/5ml, Konzentrat zur Herstellung einer Infusionslösung, , 178.35, -9.9%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer62348002 ZulassungsinhaberTeva Pharma AGNameZoledronat-Teva onco 4mg/5ml, Konzentrat zur Herstellung einer InfusionslösungRegistrierungsdatum29.03.2012Original/GenerikumGenerikumErstzulassung Sequenz29.03.2012ATC-KlassierungZoledronsäure (M05BA08)Revisionsdatum WHOWHO-DDDGültig bis28.03.2022Index Therapeuticus (BSV)07.99.Packungsgrösse Index Therapeuticus (Swissmedic)07.99.Beschreibung AbgabekategorieB  SL EintragJaAnwendungKnoche...

ODDB -Open Drug Database

24-1-2018

CEFUROXIME AXETIL Tablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]

CEFUROXIME AXETIL Tablet, Film Coated [PD-Rx Pharmaceuticals, Inc.]

Updated Date: Jan 24, 2018 EST

US - DailyMed

1-1-2018

01.01.2018: Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion, , 2095.15, -13.0%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer65964001 ZulassungsinhaberRoche Pharma (Schweiz) AGNameHerceptin subkutan 600mg/5ml, Lösung zur subkutanen InjektionRegistrierungsdatum24.11.2016  Erstzulassung Sequenz24.11.2016ATC-KlassierungTrastuzumab (L01XC03)Revisionsdatum WHOWHO-DDDGültig bis23.11.2021Index Therapeuticus (BSV)07.16.10.Packungsgrösse Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungMammakarzinom im Frühst...

ODDB -Open Drug Database

28-12-2017

CEFUROXIME AXETIL Tablet [Lupin Pharmaceuticals, Inc.]

CEFUROXIME AXETIL Tablet [Lupin Pharmaceuticals, Inc.]

Updated Date: Dec 28, 2017 EST

US - DailyMed

6-12-2017

CEFUROXIME AXETIL Tablet, Film Coated [Wockhardt USA LLC.]

CEFUROXIME AXETIL Tablet, Film Coated [Wockhardt USA LLC.]

Updated Date: Dec 6, 2017 EST

US - DailyMed

16-11-2017

CEFUROXIME AXETIL Tablet [Lake Erie Medical DBA Quality Care Products LLC]

CEFUROXIME AXETIL Tablet [Lake Erie Medical DBA Quality Care Products LLC]

Updated Date: Nov 16, 2017 EST

US - DailyMed

16-11-2017

CEFUROXIME AXETIL Tablet [Aurobindo Pharma Limited]

CEFUROXIME AXETIL Tablet [Aurobindo Pharma Limited]

Updated Date: Nov 16, 2017 EST

US - DailyMed

30-10-2017

CEFUROXIME AXETIL Tablet [A-S Medication Solutions]

CEFUROXIME AXETIL Tablet [A-S Medication Solutions]

Updated Date: Oct 30, 2017 EST

US - DailyMed

21-8-2017

X (Cefuroxime Axetil) Powder [AX Pharmaceutical Corp]

X (Cefuroxime Axetil) Powder [AX Pharmaceutical Corp]

Updated Date: Aug 21, 2017 EST

US - DailyMed

1-8-2017

CEFUROXIME AXETIL Tablet [Golden State Medical Supply, Inc.]

CEFUROXIME AXETIL Tablet [Golden State Medical Supply, Inc.]

Updated Date: Aug 1, 2017 EST

US - DailyMed

18-7-2017

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals,Inc.]

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals,Inc.]

Updated Date: Jul 18, 2017 EST

US - DailyMed

3-7-2017

CEFUROXIME AXETIL Tablet, Film Coated [Unit Dose Services]

CEFUROXIME AXETIL Tablet, Film Coated [Unit Dose Services]

Updated Date: Jul 3, 2017 EST

US - DailyMed

19-6-2017

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals, Inc.]

CEFUROXIME AXETIL Tablet [NuCare Pharmaceuticals, Inc.]

Updated Date: Jun 19, 2017 EST

US - DailyMed

22-5-2017

CEFUROXIME AXETIL Tablet, Film Coated [Ascend Laboratories, LLC]

CEFUROXIME AXETIL Tablet, Film Coated [Ascend Laboratories, LLC]

Updated Date: May 22, 2017 EST

US - DailyMed

13-4-2017

Cefuroxim-saar® 750 mg / 1500 mg

Rote - Liste

Advertisement